News
23 Aug 2019
Skyepharma is continuing its successful transformation to a fully integrated, expert and agile CDMO
Over the last two years a significant and highly successful transformation has taken place at the Skyepharma site in Lyon, France.
The mission has been to transform the site into an end-to-end contract development and manufacturing organisation (CDMO) with services extending from early stage development and manufacturing through to packaging, serialisation and aggregation included.
The journey began in July 2016 and has been organised around four core strands of activity – culture change, pharmaceutical development growth, strong investments in industrial equipment and business development.
David Lescuyer, President of Skyepharma tells about our journey in the interview by PharmaBoardRoom:
Mentioned Companies
Skyepharma Production S.A.S
